Marianne P. Allen

Array ( [id] => 1347466 [patent_doc_number] => 06583121 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-24 [patent_title] => 'System for the in vivo delivery and expression of heterologous genes in the bone marrow' [patent_app_type] => B1 [patent_app_number] => 09/367764 [patent_app_country] => US [patent_app_date] => 1999-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46482 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/583/06583121.pdf [firstpage_image] =>[orig_patent_app_number] => 09367764 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1486070 [patent_doc_number] => 06365715 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-02 [patent_title] => 'Human cardiac/brain tolloid-like protein' [patent_app_type] => B1 [patent_app_number] => 09/432473 [patent_app_country] => US [patent_app_date] => 1999-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13035 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/365/06365715.pdf [firstpage_image] =>[orig_patent_app_number] => 09432473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1419614 [patent_doc_number] => 06514939 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-04 [patent_title] => 'Atrial natriuretic factor mutants and ischemic stroke' [patent_app_type] => B1 [patent_app_number] => 09/428929 [patent_app_country] => US [patent_app_date] => 1999-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 20839 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/514/06514939.pdf [firstpage_image] =>[orig_patent_app_number] => 09428929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1576769 [patent_doc_number] => 06447773 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-10 [patent_title] => 'Member of ATP dependent protease family, clpL' [patent_app_type] => B1 [patent_app_number] => 09/416874 [patent_app_country] => US [patent_app_date] => 1999-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14823 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/447/06447773.pdf [firstpage_image] =>[orig_patent_app_number] => 09416874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6132708 [patent_doc_number] => 20020077754 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'PHARMACOPHORE FINGERPRINTING IN PRIMARY LIBRARY DESIGN' [patent_app_type] => new [patent_app_number] => 09/416550 [patent_app_country] => US [patent_app_date] => 1999-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 20034 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20020077754.pdf [firstpage_image] =>[orig_patent_app_number] => 09416550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1068625 [patent_doc_number] => 06844151 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-01-18 [patent_title] => 'Methods for production of arrays with modified oligonucleotide and polynucleotide compositions' [patent_app_type] => utility [patent_app_number] => 09/408761 [patent_app_country] => US [patent_app_date] => 1999-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13765 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/844/06844151.pdf [firstpage_image] =>[orig_patent_app_number] => 09408761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 648917 [patent_doc_number] => 07115381 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-10-03 [patent_title] => 'Methods for treating cardiovascular disorders' [patent_app_type] => utility [patent_app_number] => 09/400492 [patent_app_country] => US [patent_app_date] => 1999-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 46 [patent_no_of_words] => 28347 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/115/07115381.pdf [firstpage_image] =>[orig_patent_app_number] => 09400492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4092051 [patent_doc_number] => 06133423 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'Don-1 gene and polypeptides and uses therefor' [patent_app_type] => 1 [patent_app_number] => 9/398496 [patent_app_country] => US [patent_app_date] => 1999-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 33540 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/133/06133423.pdf [firstpage_image] =>[orig_patent_app_number] => 398496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4411385 [patent_doc_number] => 06310182 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => 'Compositions for the diagnosis and treatment of Chediak-Higashi syndrome' [patent_app_type] => 1 [patent_app_number] => 9/396540 [patent_app_country] => US [patent_app_date] => 1999-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 90 [patent_figures_cnt] => 94 [patent_no_of_words] => 59462 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/310/06310182.pdf [firstpage_image] =>[orig_patent_app_number] => 396540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1435785 [patent_doc_number] => 06355428 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-12 [patent_title] => 'Nucleic acid ligand interaction assays' [patent_app_type] => B1 [patent_app_number] => 09/393783 [patent_app_country] => US [patent_app_date] => 1999-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 25 [patent_no_of_words] => 13484 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 172 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/355/06355428.pdf [firstpage_image] =>[orig_patent_app_number] => 09393783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4380100 [patent_doc_number] => 06294357 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-25 [patent_title] => 'FabF from Staphylococcus aureus' [patent_app_type] => 1 [patent_app_number] => 9/386875 [patent_app_country] => US [patent_app_date] => 1999-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16759 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/294/06294357.pdf [firstpage_image] =>[orig_patent_app_number] => 386875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1423692 [patent_doc_number] => 06535820 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-18 [patent_title] => 'Crystalline farnesyl protein transferase compositions and methods for use' [patent_app_type] => B1 [patent_app_number] => 09/383364 [patent_app_country] => US [patent_app_date] => 1999-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 282385 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/535/06535820.pdf [firstpage_image] =>[orig_patent_app_number] => 09383364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 675544 [patent_doc_number] => 07087378 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-08-08 [patent_title] => 'Design, synthesis and use of specific polyamide DNA-binding ligands' [patent_app_type] => utility [patent_app_number] => 09/372474 [patent_app_country] => US [patent_app_date] => 1999-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 102430 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 474 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/087/07087378.pdf [firstpage_image] =>[orig_patent_app_number] => 09372474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1421796 [patent_doc_number] => 06539309 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-25 [patent_title] => 'Crystallizable farnesyl protein transferase compositions, crystals thereby obtained, and methods for use' [patent_app_type] => B1 [patent_app_number] => 09/364182 [patent_app_country] => US [patent_app_date] => 1999-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 227005 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/539/06539309.pdf [firstpage_image] =>[orig_patent_app_number] => 09364182 [rel_patent_id] =>[rel_patent_doc_number] =>)